Skip to main content
News

Policy Changes Could Cut Short a Golden Age of Drug Development | RealClearPolicy

By February 13, 2023No Comments
Cursor and female scientist studying molecule model 2022 12 16 22 26 57 utc jpg

Cursor and female scientist studying molecule model 2022 12 16 22 26 57 utc jpg2022 was an incredibly productive year for American scientists. Biopharmaceutical researchers conducted over 7,000 clinical programs, including more than 3,000 for cancer, 182 for cardiovascular diseases, 111 for Alzheimer’s, and 57 for Type II diabetes. Importantly, 77% of these therapeutics originated at small biotech companies working toward their first breakthrough.

 

{iframe}https://www.realclearpolicy.com/articles/2023/02/07/policy_changes_could_cut_short_a_golden_age_of_drug_development_880200.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.